Door to needle times bulls' eye or just bull? The effect of reducing door to needle times on the appropriate administration of thrombolysis: Implications and recommendations

European Journal of Cardiovascular Nursing

Volumn 2, Issue 1, 2003, Pages 39-45

  Clare, Carl ^a,c   Bullock, Ian ^a,b  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Audit; Myocardial infarction; Thrombolysis

Indexed keywords

HEPARIN; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; BALLOON DILATATION; BLEEDING; BLOOD CLOT LYSIS; CONSERVATIVE TREATMENT; CORONARY RISK; DIAGNOSTIC ERROR; HEALTH CARE; HEALTH CARE POLICY; HEART CATHETERIZATION; HEART LEFT BUNDLE BRANCH BLOCK; HUMAN; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; VASCULAR PATENCY;

GREAT BRITAIN; GUIDELINE ADHERENCE; HEALTH CARE REFORM; HEALTH SERVICES RESEARCH; HUMANS; MEDICAL AUDIT; MYOCARDIAL INFARCTION; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SELECTION; PRACTICE GUIDELINES; SAFETY MANAGEMENT; STATE MEDICINE; THROMBOLYTIC THERAPY; TIME FACTORS; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME;

EID: 0037492811     PISSN: 14745151     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-5151(03)00005-7     Document Type: Review

References (50)

1. Boersma E., Maas A., Deckers J., Simoons M. Early thrombolytic treatment in acute myocardial infarction reappraisal of the golden hour. Lancet. 348:1996;771-775.
2. Acute myocardial infarction: pre hospital and in hospital management. The Task Force on the Management of the Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 17:1996;43-63.
3. Birkhead J. Thrombolytic treatment for myocardial infarction an examination of practice in 39 United Kingdom hospitals. Heart. 78:1997;28-33.
4. Saturno P., Felices F., Segura J., Vera A., Rodriguez J. Reducing time delay in the thrombolysis of myocardial infarction an internal quality improvement project. Am J Med Quality. 15:2000;85-93.
5. Hourigan C., Mountain D., Langton P., et al. Changing the site of delivery of thrombolytic treatment for acute myocardial infarction from the coronary care unit to the emergency department greatly reduces door to needle time. Heart. 84:2000;157-163.
6. Kucia A., Taylor K., Horowitz J. Can a nurse trained in coronary care expedite emergency department management of patients with acute coronary syndromes. Heart Lung. 30:2001;186-190.
7. Somauroo J., McCarten P., Appleton B., Amadi A., Rodrigues E. Effectiveness of a 'thrombolysis nurse' in shortening delay to thrombolysis in acute myocardial infarction. J R Coll Phys Lond. 33:1999;46-50.
8. British Heart Foundation. Coronary Heart Disease Statistics. 2000 ed. London: British Heart Foundation, 2000.
9. Department of Health. Saving lives: Our Healthier Nation. London: The Stationery Office, 1999.
10. Krumholz H., Murillo J., Chen J., et al. Thrombolytic therapy for eligible elderly patients with acute myocardial infarction. JAMA. 277:1997;1683-1688.
11. Lambrew C., Bowlby L., Rogers W., Chandra N., Weaver D. Factors influencing the time to thrombolysis in acute myocardial infarction. Arch Internal Med. 157:1997;2577-2582.
12. Department of Health. National Service Framework for Coronary Heart Disease. London: The Stationery Office, 2000.
13. Department of Health. The New NHS. Modern. Dependable. London: The Stationery Office, 1998.
14. Department of Health. A First Class Service. London: The Stationery Office, 1998.
15. Birkhead J. Trends in the provision of thrombolytic treatment between 1993 and 1997. Heart. 82:1999;438-442.
16. Habib G. Current status of thrombolysis in acute myocardial infarction: optimal selection and delivery of thrombolytic drugs. Chest. 107:1995;225-232.
17. NHS Executive. Health Service Circular: HSC1999/065. Clinical Governance in the New NHS. London: NHS Executive, 1999.
18. DeWood M., Spores J., Notske R., et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. New Engl J Med. 303:1980;897-902.
19. Braunwald E. The open artery theory is alive and well - again. New Engl J Med. 329:1993;1650-1652.
20. An international randomised trial comparing four thrombolytic strategies for acute myocardial infarction. New Engl J Med. 329:1993;673-682.
21. Cairns J., Armstrong P., Belenkie I., et al. Maximising the benefits of thrombolytic therapy for acute myocardial infarction. Can Med Assoc J. 152:1995;819-822.
22. Indications for Fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all trials of more than 1000 patients. Lancet. 343:1994;311-322.
23. Cairns J. Coronary thrombolysis: mortality trials. Can J Cardiol. 9:1993;490-497.
24. Cairns J., Kennedy J., Fuster V. Coronary thrombolysis. Chest. 114:1998;634S-657S.
25. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. New Engl J Med. 336:1997;1624-1628.
26. Every N., Paesons L., Hlatky M., Martin J., Weaver W. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. New Engl J Med. 335:1996;1253-1260.
27. Aversano T., Aversano L., Passamani E., et al. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery. A randomised controlled trial. J Am Med Assoc. 287:2002;1943-1951.
28. Reimer K., Vander Heide R., Richard V. Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models. Am J Cardiol. 72:1993;13G-21G.
29. Effect of time from onset to coming under care on fatality of patients with acute myocardial infarction: effect of resuscitation and thrombolytic treatment. Heart. 80:1998;114-120.
30. Rogers W., Canto L., Lambrew C., et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: The National Registry Of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol. 36:2000;2056-2063.
31. Edhouse J., Sakr M., Wardrope J., Morris F. Thrombolysis in acute myocardial infarction: the safety and efficiency of treatment in the accident and emergency department. J Accid Emerg Med. 16:1999;325-330.
32. Hirvonen T., Halinen M., Kala R., Olkinuora J. Delays in thrombolytic therapy for acute myocardial infarction in Finland. Eur Heart J. 19:1998;885-892.
33. Bharat V., Tripathy S., Guha A., Mitra A. Fast track thrombolysis in acute myocardial infarction: a quality improvement project. Indian Heart J. 50:1998;167-171.
34. Palmer D., Cox K., Dear K., Leitch J. Factors associated with delay in giving thrombolytic therapy after arrival at hospital. Med J Aust. 168:1998;111-114.
35. Kendall J., McCabe S. The use of audit to set up a thrombolysis programme in the accident and emergency department. J Accid Emerg Med. 13:1996;49-53.
36. Markel K., Marion S. CQI: improving the time to thrombolytic therapy for patients with acute myocardial infarction in the emergency department. J Emerg Med. 15:1996;725-726.
37. Blank F., Austin M., Bennett A., et al. Decreasing the door to thrombolysis time at one busy acute care hospital. J Emerg Nurs. 21:1995;202-207.
38. Maynard C., Weaver W., Lambrew C., Bowlby L., Rogers W., Rubison R. Factors influencing the time to administration of thrombolytic therapy with recombinant tissue plasminogen activator. Am J Cardiol. 76:1995;548-552.
39. Kline E., Smith D., Martin J., et al. In hospital treatment delays in patients treated with thrombolytic therapy: a report of the GUSTO time to treatment substudy. Circulation. 86:1992;I702.
40. Saetta J., Quinton D., Dacruz D., Barnes M. Delay in thrombolytic treatment in acute myocardial infarction: the role of the accident and emergency department. Arch Emerg Med. 7:1990;206-211.
41. Pope J., Aufderheide T., Ruthazer R., et al. Missed diagnoses of acute cardiac ischaemia in the emergency department. New Engl J Med. 342:2000;1163-1170.
42. Lambrew C., Weaver W., Rogers W., Bowlby, Rubison R., French W. Hospital protocols and policies that may delay early identification and thrombolytic treatment of acute myocardial infarction patients. J Thromb Thrombolys. 3:1996;301-306.
43. Castillo P., Palmer C., Halpern M., Hatziandrou E., Gersh B. Cost effectiveness of thrombolytic therapy for acute myocardial infarction. Ann Pharmacother. 31:1997;596-603.
44. Robinson M., Thompson E., Black N. Evaluation of the effectiveness of guidelines, audit and feedback: improving the use of intravenous thrombolysis in patients with suspected acute myocardial infarction. Int J Qual Health Care. 8:1996;211.
45. Ryan T., Anderson J., Antman E., et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 28:1996;1328-1428.
46. Lloyd G., Roberts A., Bashir I., Mumby M., Kamalvand K., Cooke R. An audit of nurse practitioner led thrombolysis to improve the treatment of acute myocardial infarction. J Public Health Med. 22:2000;462-465.
47. Al-Mohammad A., Fath-Ordoubadi F., Amadi A., Beatt K. Can the pressure to achieve short door to needle time lead to inappropriate thrombolysis? Br Heart J. 73:1995;48.
48. Kelion A., Banning A., Shahi M., Bell J. The effect of reduction of door to needle times on the administration of thrombolytic therapy for acute myocardial infarction. Postgrad Med J. 74:1998;533-536.
49. Chan W., Leung K., Lee Y., Hung N., Lau F. Undiagnosed acute myocardial infarction in the accident and emergency department: reasons and implications. Eur J Emerg Med. 5:1998;219-224.
50. Booth J, Craig O, Fraser L, Marsh A. Revealed: the NHS scandal of 'his' and 'hers' trolley corridors. Sunday Telegraph 2001;August 26:3.